Breymann, C <br/><br/>
Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.  [electronic resource] 

 -  American journal of obstetrics and gynecology  Mar 2001 
 - 662-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0002-9378 
<br/><br/><label>Standard No.: </label>10.1067/mob.2001.111717  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia, Iron-Deficiency--blood<br/>Erythrocyte Count<br/>Erythrocyte Indices<br/>Erythropoietin--administration & dosage<br/>Female<br/>Ferric Compounds--administration & dosage<br/>Ferric Oxide, Saccharated<br/>Ferritins--blood<br/>Fetal Growth Retardation--complications<br/>Glucaric Acid<br/>Hematocrit<br/>Humans<br/>Placental Insufficiency--complications<br/>Pregnancy<br/>Pregnancy Complications--drug therapy<br/>Pregnancy Outcome<br/>Recombinant Proteins<br/>Reticulocyte Count<br/>Transferrin--analysis<br/>Treatment Outcome<br/>Ultrasonography